AI
AdvanCell, Inc.
SEC filingBiotechnology · Cambridge, MA
Amount raised$218.3Msold at filing
Total offering$315M$96.7M still open
Investors in the raise41count reported to the SEC
FiledJul 16, 2026first sale Jun 30, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Andrew KayDirector
Philina LeeExecutive Officer, Director
Jamil BegDirector
Kevin CameronDirector
Christopher GagliardiDirector
Bali MuralidharDirector
Wing Cheong LamDirector
Andrew AdamovichDirector
Aaron PickettExecutive Officer
Nik EconomopoulosDirector
Anthony AiudiDirector
Executive officers, directors and promoters as listed on the Form D.